Pearl and ClearDent Partner to Expand Access to Dental AI Disease Detection in Canada

Key Takeaways

• Pearl's Second Opinion AI now native in ClearDent's platform
• Integration available to all Canadian ClearDent users via API
• AI detects caries, calculus, periapical lesions in real time
• Partnership aims to boost AI adoption through webinars and training
• Pearl's AI holds regulatory clearance in 120 countries

Pulse Analysis

Artificial intelligence is moving from experimental labs into everyday dental practice, and the Pearl‑ClearDent partnership exemplifies that shift. Pearl, the first company to receive FDA clearance for an AI that reads dental X‑rays, brings a proven detection engine that already serves clinics in more than 120 countries. ClearDent, founded in 2002, dominates the Canadian practice‑management market with a platform built for local regulatory and privacy requirements. By embedding Pearl’s Second Opinion® directly into ClearDent’s software, the two firms create a seamless, cloud‑based solution that eliminates the need for separate AI subscriptions or manual image uploads.

For clinicians, the integration translates into real‑time decision support at the point of care. The AI evaluates radiographs for caries, calculus, periapical radiolucencies and other pathologies, flagging findings instantly within the existing workflow. This reduces diagnostic latency, standardizes interpretation across practitioners, and helps dentists communicate risk more clearly to patients. ClearDent’s API ensures that the AI runs on the same secure servers that host patient records, preserving data privacy while delivering faster turnaround times. Early adopters report higher case acceptance rates and fewer repeat visits for missed lesions.

The collaboration also signals a broader strategic push by dental‑tech vendors to lock in market share through native AI capabilities. As Canadian insurers begin to recognize AI‑assisted diagnostics for reimbursement, practices that leverage Pearl’s technology may gain a cost‑advantage and improve quality metrics. Competitors such as Denti.AI and Overjet are racing to secure similar integrations, but Pearl’s extensive regulatory clearance and established developer ecosystem give it a head start. Ongoing webinars and joint training programs aim to demystify AI for clinicians, setting the stage for wider adoption across North America in the coming years.